AB 392

This bill prohibits health insurance policies, and self-insured governmental

and school district health plans, that cover injected or intravenous and oral

chemotherapy from requiring the insured to pay a higher copayment, deductible, or

coinsurance for oral chemotherapy than is required for injected or intravenous

chemotherapy, regardless of the formulation or benefit category determination by

the policy or plan. A health insurance policy or self-insured governmental or school

district health plan may not comply with that prohibition by increasing the

copayment, deductible, or coinsurance for intravenous or injected chemotherapy

that is covered under the policy or plan.

The requirements of the bill apply to individual and group health insurance

policies, including limited service health organizations, preferred provider plans,

defined network plans, and cooperative associations' health care plans; to health

care plans, including a self-insured plan, offered by the state to its employees; and

to self-insured health plans of a city, town, village, county, or school district.